| Antiapoptotic properties of α-crystallin–derived peptide chaperones and characterization of their uptake transporters in human RPE cells PG Sreekumar, P Chothe, KK Sharma, R Baid, U Kompella, C Spee, ... Investigative ophthalmology & visual science 54 (4), 2787-2798, 2013 | 52 | 2013 |
| Modifier genes as therapeutics: the nuclear hormone receptor Rev Erb alpha (Nr1d1) rescues Nr2e3 associated retinal disease NM Cruz, Y Yuan, BD Leehy, R Baid, U Kompella, MM DeAngelis, ... PloS one 9 (1), e87942, 2014 | 40 | 2014 |
| Investigating thiol‐modification on hyaluronan via carbodiimide chemistry using response surface methodology S Santhanam, J Liang, R Baid, N Ravi Journal of Biomedical Materials Research Part A 103 (7), 2300-2308, 2015 | 26 | 2015 |
| Asterixis R Agarwal, R Baid Journal of postgraduate medicine 62 (2), 115-117, 2016 | 22 | 2016 |
| LEDGF1-326 Decreases P23H and Wild Type Rhodopsin Aggregates and P23H Rhodopsin Mediated Cell Damage in Human Retinal Pigment Epithelial Cells R Baid, RI Scheinman, T Shinohara, DP Singh, UB Kompella PloS one 6 (9), e24616, 2011 | 15 | 2011 |
| Biosynthesis, Characterization, and Efficacy in Retinal Degenerative Diseases of Lens Epithelium-derived Growth Factor Fragment (LEDGF1–326), a Novel Therapeutic Protein R Baid, AK Upadhyay, T Shinohara, UB Kompella Journal of Biological Chemistry 288 (24), 17372-17383, 2013 | 9 | 2013 |
| Powdered gloves: Time to bid adieu R Baid, R Agarwal Journal of Postgraduate Medicine 63 (3), 206, 2017 | 8 | 2017 |
| Protein Drug Delivery and Formulation Development B R Drug Product Development for the Back of the Eye, 409-448, 2011 | 5* | 2011 |
| LEDGF peptides and formulations thereof for treatment of degenerative disorders UB Kompella, R Baid, AK Upadhyay, S Yandrapu US Patent 9,526,760, 2016 | 1 | 2016 |
| Efficacy of nanoparticle-based gene delivery for rescuing Nr2e3 associated retinal degeneration NM Cruz, Y Yuan, R Baid, U Kompella, NB Haider Investigative Ophthalmology & Visual Science 53 (14), 1884-1884, 2012 | 1 | 2012 |
| Ledgf-peptider og formuleringer deraf til behandling af degenerative lidelser UB Kompella, AK Upadhyay, R Baid, S Yandrapu | | 2020 |
| LEDGF peptides and formulations thereof for treatment of degenerative disorders UB Kompella, R Baid, AK Upadhyay, S Yandrapu US Patent 10,221,226, 2019 | | 2019 |
| C69 WAITING TO INHALE: AEROSOL, DELIVERY, AND OUTCOMES: Targeted Delivery Of Protease-Resistant Ec-Sod To The Pulmonary Artery L Villegas, A Ben-Masaud, C Woods, R Baid, R Trivedi, U Kompella, ... American Journal of Respiratory and Critical Care Medicine 191, 1, 2015 | | 2015 |
| Optimization of Thiolation for Biomimetic Vitreous Substitute S Santhanam, R Baid, N Ravi Investigative Ophthalmology & Visual Science 55 (13), 5278-5278, 2014 | | 2014 |
| Hydrogels for cell-based intra-vitreal drug delivery R Baid, S Bhaladhare, N Ravi Investigative Ophthalmology & Visual Science 55 (13), 475-475, 2014 | | 2014 |
| Lens epithelium derived growth factor (1-326): a new protein drug for retinal diseases R Baid University of Colorado, 2013 | | 2013 |
| Rescue of Nr2e3 Associated Retinal Degeneration Using Nanoparticle Based Gene Delivery NB Haider, Y Yuan, N Mollema, B Leehy, R Baid, UB Kompella Investigative Ophthalmology & Visual Science 52 (14), 431-431, 2011 | | 2011 |
| Outstanding Reviewers of 2010 C Agarwal, R Agarwal, B Aggarwal, M Ahmad, CH Ahn, F Ahsan, H Akita, ... Pharm Res 28, 421-422, 2011 | | 2011 |
| LEDGF Decreases Damage Mediated by Rhodopsin P23H Aggregation in Human ARPE-19 Cells R Baid, R Scheinman, T Shinohara, UB Kompella Investigative Ophthalmology & Visual Science 51 (13), 699-699, 2010 | | 2010 |
